Publications by authors named "S S Smetana"

Hyperimmunoglobulin E syndrome (HIGES) is a rare immunodeficiency characterized by high levels of immunoglobulin E (IgE) in the setting of various clinical features such as cutaneous candidiasis, asthma, recurrent rashes, and fungal infections. This case describes a 70-year-old male with cachexia and dyspnea found to have a cavitary lesion and aspergilloma, with remarkably high IgE and positive 1,3-β-D-glucan and Aspergillus testing. Herein, we describe the aforementioned case, review the available literature, and hypothesize the connection between invasive fungal infections and HIGES.

View Article and Find Full Text PDF
Article Synopsis
  • The food production industry heavily depends on fossil fuels, leading to significant emissions and reliance on a limited number of fuel suppliers, which presents various challenges.
  • This review explores ways to reduce fossil fuel use in food processing by highlighting the potential for clean and renewable energy alternatives, such as geothermal heating and electrical boilers.
  • It emphasizes that while long-term solutions are necessary, immediate actions like optimizing processes and using smart sensors can help decrease energy consumption, and discusses the investment needed to implement these strategies effectively.
View Article and Find Full Text PDF

Plant-based foods are increasing in popularity as more and more people are concerned about personal and planetary health. The consumption of plant-based dairy alternatives (PBDAs) has assumed a more significant dietary role in populations shifting to more sustainable eating habits. Plant-based drinks (PBDs) made from soya and other legumes have ample protein levels.

View Article and Find Full Text PDF

Background: Empagliflozin reduces the risk of cardiovascular disease (CVD) in patients with type 2 diabetes (T2DM) and high cardiovascular risk via mechanisms which have not been fully explained. The mechanisms of such benefit have not been fully understood, and whether empagliflozin can be safely administered as first-line treatment in patients with CVD at the initial stages of glycaemic perturbations remains to be established. We investigated the effects of empagliflozin on insulin resistance, insulin sensitivity and β-cell function indexes in patients with a recent acute coronary event and newly detected dysglycaemia, i.

View Article and Find Full Text PDF